triamcinolone has been researched along with Pulmonary Disease, Chronic Obstructive in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyd, AS; Ortleb, M | 1 |
| Calverley, P; Celli, BR; Chambers, M; Clark, JF; Hawkins, N; Scott, DA; Thompson, JC; Woods, B | 1 |
| Marchand, E | 1 |
| Gillissen, A; Welte, T | 1 |
| Bailey, WC; Eichenhorn, MS; Gerald, LB; Madhok, TC; Scanlon, PD; Tashkin, DP; Wise, RA | 1 |
| Bailey, WC; Buist, AS; Carpenter, PC; Connett, JE; Eichenhorn, M; Kanner, RE; Madhok, T; Scanlon, PD; Skeans, M; Tashkin, DP; Weinmann, G; Wise, RA | 1 |
4 review(s) available for triamcinolone and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Vancomycin-associated neutrophilic dermatitis histologically mimicking Cryptococcus.
Topics: Biopsy, Needle; Coronary Artery Disease; Cryptococcus; Dermatomycoses; Diagnosis, Differential; Drug Eruptions; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunohistochemistry; Kidney Failure, Chronic; Male; Metronidazole; Middle Aged; Pulmonary Disease, Chronic Obstructive; Renal Dialysis; Risk Assessment; Severity of Illness Index; Treatment Outcome; Triamcinolone; Vancomycin | 2014 |
Mortality and drug therapy in patients with chronic obstructive pulmonary disease: a network meta-analysis.
Topics: Albuterol; Aminopyridines; Beclomethasone; Benzamides; Benzyl Alcohols; Bronchodilator Agents; Budesonide; Chlorobenzenes; Cyclopropanes; Fluticasone-Salmeterol Drug Combination; Formoterol Fumarate; Glucocorticoids; Humans; Indans; Ipratropium; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Quinolones; Survival Rate; Theophylline; Tiotropium Bromide; Triamcinolone | 2015 |
[Long-term trials assessing pharmacological treatments in COPD: lessons and limitations].
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adult; Aged; Albuterol; Androstadienes; Bronchodilator Agents; Budesonide; Combined Modality Therapy; Drug Therapy, Combination; Female; Fluticasone; Humans; Ipratropium; Long-Term Care; Male; Middle Aged; Prednisone; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Salmeterol Xinafoate; Scopolamine Derivatives; Smoking Cessation; Tiotropium Bromide; Triamcinolone | 2010 |
[Do we need inhalative steroids in chronic COPD patients?].
Topics: Administration, Inhalation; Administration, Topical; Adrenergic beta-Agonists; Androstadienes; Anti-Inflammatory Agents; Bronchodilator Agents; Budesonide; Cholinergic Antagonists; Double-Blind Method; Fluticasone; Forced Expiratory Volume; Glucocorticoids; Humans; Ipratropium; Multicenter Studies as Topic; Placebos; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Risk; Smoking; Theophylline; Time Factors; Triamcinolone | 2002 |
2 trial(s) available for triamcinolone and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Lack of long-term adverse adrenal effects from inhaled triamcinolone: Lung Health Study II.
Topics: Administration, Inhalation; Adrenal Glands; Anti-Inflammatory Agents; Female; Humans; Hydrocortisone; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Time Factors; Triamcinolone | 2003 |
Loss of bone density with inhaled triamcinolone in Lung Health Study II.
Topics: Administration, Inhalation; Bone Density; Bone Resorption; Double-Blind Method; Female; Glucocorticoids; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Time Factors; Triamcinolone | 2004 |
1 other study(ies) available for triamcinolone and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Use of ozone-depleting substances; removal of essential-use designation (flunisolide, etc.). Final rule.
Topics: Air Pollutants; Air Pollution; Albuterol; Anti-Asthmatic Agents; Asthma; Atmosphere; Bronchodilator Agents; Chemistry, Pharmaceutical; Chlorofluorocarbons; Drug Costs; Drug Therapy, Combination; Fluocinolone Acetonide; Humans; Ipratropium; Metaproterenol; Nebulizers and Vaporizers; Ozone; Pulmonary Disease, Chronic Obstructive; Triamcinolone; United States | 2010 |